The interactions between saroglitazar and ferulic acid with different enzymes and metabolites involved in metabolic dysfunction-associated fatty liver disease (MASLD), such as SORD, HK1, HK2, MgATP, KHK, HK3, ALDOB, ALDOC, and fructose-1-phosphate (F1P) (Figure 2). This evidence concerns the gene KHK and metabolic dysfunction-associated steatotic liver disease.